Showing results (141-150 of 5,696) with videos related to

Sort By:
Pageof 570
Medical Oncology (Northwood, London, England)|May 25, 2006
Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients: a phase 2 trialRony M Abou-Jawde, Janice Reed, Megan Kelly, et al.
Medical Oncology (Northwood, London, England)|May 19, 2021
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistanceLuca Triggiani, Rosario Mazzola, Davide Tomasini, et al.
Medical Oncology (Northwood, London, England)|May 19, 2021
The function of Cav-1 in MDA-MB-231 breast cancer cell migration and invasion induced by ectopic ATP5BXinjie Dong, Yilei Li, Wei Li, et al.
Medical Oncology (Northwood, London, England)|February 19, 1998
Lack of toxicity associated with the systemic administration of antisense oligonucleotides for treatment of rats bearing LNCaP prostate tumorsM Rubenstein, Y Mirochnik, V Ray, et al.
Medical Oncology (Northwood, London, England)|February 19, 1998
In vitro colony formation from fetal liver cells and their infusions in patients of aplastic anaemiaS Sharma, H P Pati, A Mohanty
Medical Oncology (Northwood, London, England)|February 19, 1998
Phase II trial of merbarone in patients with malignant brain tumorsU R Malik, J P Dutcher, G Caliendo, et al.
Medical Oncology (Northwood, London, England)|February 19, 1998
A novel second line chemotherapy treatment of recurrent thymomaN Jan, G M Villani, J Trambert, et al.
Medical Oncology (Northwood, London, England)|April 19, 2020
Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancerJamal Hallajzadeh, Parisa Maleki Dana, Moein Mobini, et al.
Medical Oncology (Northwood, London, England)|June 13, 2020
NUC-1031, use of ProTide technology to circumvent gemcitabine resistance: current status in clinical trialsZainul Abedin Kapacee, Jennifer J Knox, Daniel Palmer, et al.
Medical Oncology (Northwood, London, England)|June 1, 2020
Progranulin expression induced by follicle-stimulating hormone in ovarian cancer cell lines depends on the histological subtypeCarlos Eduardo Perez-Juarez, Fabian Arechavaleta-Velasco, Carmen Mendez, et al.
Pageof 570